KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Shares Outstanding (Weighted Average): 2009-2024

Historic Shares Outstanding (Weighted Average) for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $81.9 million.

  • Idexx Laboratories' Shares Outstanding (Weighted Average) fell 2.80% to $80.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.0 million, marking a year-over-year decrease of 2.80%. This contributed to the annual value of $81.9 million for FY2024, which is 1.45% down from last year.
  • Idexx Laboratories' Shares Outstanding (Weighted Average) amounted to $81.9 million in FY2024, which was down 1.45% from $83.1 million recorded in FY2023.
  • In the past 5 years, Idexx Laboratories' Shares Outstanding (Weighted Average) registered a high of $85.3 million during FY2020, and its lowest value of $81.9 million during FY2024.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $82.6 million, with a median of $82.8 million in 2022.
  • Per our database at Business Quant, Idexx Laboratories' Shares Outstanding (Weighted Average) dropped by 2.33% in 2022 and then rose by 0.33% in 2023.
  • Yearly analysis of 5 years shows Idexx Laboratories' Shares Outstanding (Weighted Average) stood at $85.3 million in 2020, then fell by 0.59% to $84.8 million in 2021, then dropped by 2.33% to $82.8 million in 2022, then rose by 0.33% to $83.1 million in 2023, then decreased by 1.45% to $81.9 million in 2024.